The drug is approved for treatment of hypertension but has also shown renoprotective potential in patients with type 2 diabetes and albuminuria (4, 5).
2
然而,在接受抗高血压药物治疗的患者中,蛋白尿和HF没有显著相关性。
However, there was no significant association between albuminuria and HF in patients taking antihypertensive treatment.